Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

NK CELL EDUCATION

It takes a village

New insights into how NK cells are educated by the receptor NKG2D, which leads to effects on another receptor, NCR1, raise interesting questions about why so many receptors are linked to the education of NK cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The education of NK cells by NKG2D.

References

  1. Brodin, P., Kärre, K. & Höglund, P. Trends Immunol. 30, 143–149 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. He, Y. & Tian, Z. Cell. Mol. Immunol. 14, 321–330 (2017).

    Article  CAS  PubMed  Google Scholar 

  3. Raulet, D. H. & Vance, R. E. Nat. Rev. Immunol. 6, 520–531 (2006).

    Article  CAS  PubMed  Google Scholar 

  4. Jelenčić, V. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0209-9 (2018).

  5. Li, W. et al. Immunity 27, 763–774 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Raulet, D. H. Nat. Rev. Immunol. 3, 781–790 (2003).

    Article  CAS  PubMed  Google Scholar 

  7. Koch, J., Steinle, A., Watzl, C. & Mandelboim, O. Trends Immunol. 34, 182–191 (2013).

    Article  CAS  PubMed  Google Scholar 

  8. He, Y. et al. J. Autoimmun. 81, 1–12 (2017).

    Article  CAS  PubMed  Google Scholar 

  9. Wu, N. et al. Nat. Immunol. 17, 387–396 (2016).

    Article  CAS  PubMed  Google Scholar 

  10. Viant, C. et al. Nat. Commun. 5, 5108 (2014).

    Article  CAS  PubMed  Google Scholar 

  11. Guia, S. et al. Sci. Signal. 4, ra21 (2011).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to André Veillette.

Ethics declarations

Competing interests

A.V. has a contract with Bristol Myers-Squibb to study the mechanism of action of the monoclonal antibody elotuzumab (antibody to SLAMF7) in multiple myeloma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Veillette, A., Lu, Y. It takes a village. Nat Immunol 19, 1046–1047 (2018). https://doi.org/10.1038/s41590-018-0213-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-018-0213-0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing